Pathophysiological characterization of drug hypersensitivity to tribenoside

• Authors: Simona Zgažarová , Hana Jedličková , Zita Chovancová , Vojtěch Thon
• Languages of publication: EN

Abstracts

EN

Keywords

EN

Basophil activation test; Benzoic acid; Drug hypersensitivity; Lymphocyte transformation test; Patch test; Tribenoside

• Publisher: De Gruyter Open
• Journal: Open Medicine
• Year: 2014
• Volume: 9
• Issue: 1
• Pages: 159-168

Dates

published

1 - 2 - 2014

online

4 - 2 - 2014

Contributors

author

Simona Zgažarová

• 1st Department of Dermatovenereology, St. Anne’s University Hospital, Medical Faculty of Masaryk University, Brno, Czech Republic

author

Hana Jedličková

• 1st Department of Dermatovenereology, St. Anne’s University Hospital, Medical Faculty of Masaryk University, Brno, Czech Republic

author

Zita Chovancová

• Department of Clinical Immunology and Allergy, St. Anne’s University Hospital, Medical Faculty of Masaryk University, Brno, Czech Republic

author

Vojtěch Thon

• Department of Clinical Immunology and Allergy, St. Anne’s University Hospital, Medical Faculty of Masaryk University, Brno, Czech Republic

References

• [1] Hashizume H., Takigawa M., Drug-induced hypersensitivity syndrome associated with cytomegalovirus reactivation: immunological characterization of pathogenic T cells, Acta Derm. Venereol., 2005, 85, 47–50 http://dx.doi.org/10.1080/00015550410024094[Crossref]
• [2] Jaques R., The pharmacological activity of tribenoside, Pharmacology, 1977, 15, 445–460 http://dx.doi.org/10.1159/000136721[Crossref]
• [3] Kikkawa Y., Takaki S., Matsuda Y., Okabe K., Taniguchi M., Oomachi K., et al., The influence of Tribenoside on expression and deposition of epidermal laminins in HaCaT cells, Biol. Pharm. Bull., 2010, 33, 307–310 http://dx.doi.org/10.1248/bpb.33.307[Crossref][WoS]
• [4] Endo H., Kawada A., Yudate T., Aragane Y., Yamada H., Tezuka T., Drug eruption due to tribenoside, Contact Dermatitis, 1999, 41, 223 http://dx.doi.org/10.1111/j.1600-0536.1999.tb06137.x[WoS][Crossref]
• [5] Spáčil J., Pharmacotherapy of peripheral vascular diseases, In: Marek J. (Ed.), Pharmacotherapy of internal diseases, 3rd ed., Grada, Praha, 2005, 63–85
• [6] Schuppli R., Exantheme durch Glyvenol, Dermatologica, 1968, 137, 227–232 http://dx.doi.org/10.1159/000254051[Crossref]
• [7] Barbaud A., Goncalo M., Bruynzeel D., Bircher A., Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions, Contact Dermatitis, 2001, 45, 321–328 http://dx.doi.org/10.1034/j.1600-0536.2001.450601.x[Crossref]
• [8] Inoue A., Tamagawa-Mineoka R., Katoh N., Kishimoto S., Allergic contact dermatitis caused by tribenoside, Contact Dermatitis, 2009, 60, 349–350 http://dx.doi.org/10.1111/j.1600-0536.2009.01544.x[Crossref]
• [9] Posadas S.J., Pichler W.J., Delayed drug hypersensitivity reactions - new concepts, Clin. Exp. Allergy, 2007, 37, 989–999 http://dx.doi.org/10.1111/j.1365-2222.2007.02742.x[Crossref]
• [10] Barbaud A., Drug patch testing in systemic cutaneous drug allergy, Toxicology, 2005, 209, 209–216 http://dx.doi.org/10.1016/j.tox.2004.12.024[Crossref]
• [11] Brockow K., Romano A., Blanca M., Ring M., Pichler W., Demoly P., General considerations for skin test procedures in the diagnosis of drug hypersensitivity, Allergy, 2002, 57, 45–51
• [12] Wilkinson D.S., Fregert S., Magnusson B., Bandmann H.J., Calnan C.D., Cronin E., et al., Terminology of contact dermatitis, Acta Dermatovenereologica, 1970, 50, 287–292
• [13] Pichler W., Yawalkar N., Schmid S., Helbling A., Pathogenesis of drug-induced exanthems, Allergy, 2002, 57, 884–893 http://dx.doi.org/10.1034/j.1398-9995.2002.02161.x[Crossref]
• [14] Pichler W.J., Tilch J., The lymphocyte transformation test in the diagnosis of drug hypersensitivity, Allergy, 2004, 59, 809–820 http://dx.doi.org/10.1111/j.1398-9995.2004.00547.x[Crossref]
• [15] Thon V., Eggenbauer H., Wolf H.M., Fischer M.B., Litzman J., Lokaj J., et al., Antigen presentation by common variable immunodeficiency (CVID) B cells and monocytes is unimpaired, Clin. Exp. Immunol., 1997, 108, 1–8 http://dx.doi.org/10.1046/j.1365-2249.1997.d01-989.x[Crossref]
• [16] Cederbrant K., Stejskal V., Broman P., Lindkvist L., Sundell K., In vitro lymphocyte proliferation in the diagnosis of allergy to phenoxymethylpenicillin, Allergy, 1998, 53, 1155–1161 http://dx.doi.org/10.1111/j.1398-9995.1998.tb03835.x[Crossref]
• [17] Sanz M.L., Gamboa P.M., De Weck A.L., In vitro tests: Basophil activation tests, In: Pichler W.J. (Ed.), Drug hypersensitivity, 1st ed., Karger, Basel, 2007, 391–402 http://dx.doi.org/10.1159/000104216
• [18] Sanz M.L., Gamboa P.M., Antépara I., Uasuf C., Vila L., Garcia-Avilés C., et al., Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to betalactam antibiotics, Clin. Exp. Allergy, 2002, 32, 277–286 http://dx.doi.org/10.1046/j.1365-2222.2002.01305.x[Crossref]
• [19] Sioufi A., Pommier F., Biotransformation of tribenoside into benzoic acid in man, Eur. J. Drug Metab. Pharmacokinet., 1982, 7, 223–228 http://dx.doi.org/10.1007/BF03189568[Crossref]
• [20] Gregus Z., Fekete T., Halászi E., Gyurasics Á., Klaassen C.D., Effects of fibrates on the glycine conjugation of benzoic acid in rats, Drug metabolism. and disposition., 1998, 26, 1082–1088
• [21] Bell-Parikh L.C., Guengerich F.P., Kinetics of cytochrome P450 2E1-catalyzed oxidation of ethanol to acetic acid via acetaldehyde, J. Biol. Chem., 1999, 274, 23833–23840 http://dx.doi.org/10.1074/jbc.274.34.23833[Crossref]
• [22] Amunom I., Stephens L.J., Tamasi V., Cai J., Pierce W.M. Jr., Conklin D.J., et al., Cytochromes P450 catalyze oxidation of alpha, beta-unsaturated aldehydes, Arch. Biochem. Biophys., 2007, 464, 187–196 http://dx.doi.org/10.1016/j.abb.2007.05.019[WoS][Crossref]
• [23] Jacob S.E., Stechschulte S., Eyelid dermatitis associated with balsam of Peru constituents: benzoic acid and benzyl alcohol, Contact Dermatitis, 2008, 58, 111–112 http://dx.doi.org/10.1111/j.1600-0536.2007.01178.x[WoS][Crossref]
• [24] Rietschel R.L., Fowler J.F., Allergic sensitization to plants, In: Rietschel R.L., Fowler J.F. (Eds.), Fisher’s Contact Dermatitis, 6th ed., BC Decker Inc., Ontario, 2007, 405–453
• [25] Avalos-Peralta P., García-Bravo B., Camacho F.M., Sensitivity to Myroxylon pereirae resin (balsam of Peru). A study of 50 cases, Contact Dermatitis, 2005, 52, 304–306 http://dx.doi.org/10.1111/j.0105-1873.2005.00603.x[Crossref]
• [26] Tanaka S., Matsumoto Y., Dlova N., Ostlere L.S., Goldsmith P.C., Rycroft R.J. G., et al., Immediate contact reactions to fragrance mix constituents and Myroxylon pereirae resin, Contact Dermatitis, 2004, 51, 20–21 http://dx.doi.org/10.1111/j.0105-1873.2004.00326.x[Crossref]
• [27] Rajpara S., Wilkinson M.S., King C.M., Gawkrodger D.J., English J.S.C., Statham B.N., et al., The importance of propolis in patch testing-a multicentre survey, Contact Dermatitis, 2009, 61, 287–290 http://dx.doi.org/10.1111/j.1600-0536.2009.01629.x[Crossref][WoS]
• [28] Friedmann P.S., Lee M.S., Friedmann A.C., Barnetson R.C., Mechanisms in cutaneous drug hypersensitivity reactions, Clin. Exp. Allergy, 2003, 33, 861–872 http://dx.doi.org/10.1046/j.1365-2222.2003.01718.x[Crossref]
• [29] Nyfeler B., Pichler W.J., The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity, Clin. Exp. Allergy, 1997, 27, 175–181 http://dx.doi.org/10.1111/j.1365-2222.1997.tb00690.x[Crossref]
• [30] Hari Y., Frutig-Schnyder K., Hurni M., Yawalkar N., Zanni M.P., Schnyder B., et al., T cell involvement in cutaneous drug eruptions, Clin. Exp. Allergy, 2001, 31, 1398–1408 http://dx.doi.org/10.1046/j.1365-2222.2001.01164.x[Crossref]
• [31] Bruynzeel D.P., Maibach H.I., Patch testing in systemic drug eruptions, Clinics in Dermatology, 1997, 15, 479–484 http://dx.doi.org/10.1016/S0738-081X(97)00007-2[Crossref]
• [32] Gex-Collet C., Helbling A., Pichler W.J., Multiple drug hypersensitivity - proof of multiple drug hypersensitivity by patch and lymphocyte transformation tests, J. Invest. Allergol. Clin. Immunol., 2005, 15, 293–296
• [33] Merk H.F., Diagnosis of drug hypersensitivity: lymphocyte transformation test and cytokines, Toxicology, 2005, 209, 217–220 http://dx.doi.org/10.1016/j.tox.2004.12.026[Crossref]

Identifiers

DOI

10.2478/s11536-013-0248-4